L3VLUP
ProSign in

CMPS · VRTX in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

CMPSVRTX
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • CMPS
  • VRTX
010203040202120222023202420252026
Holders and value by quarter
QuarterCMPSVRTX
Q3 20203 holders, $17m31 holders, $21.9bn
Q4 20201 holders, $2.4m30 holders, $18.4bn
Q1 20212 holders, $11m31 holders, $15.4bn
Q2 20213 holders, $42m30 holders, $12.7bn
Q3 20211 holders, $3.0m35 holders, $10.1bn
Q4 2021none listed holders, n.a.28 holders, $12.4bn
Q1 2022none listed holders, n.a.23 holders, $16.1bn
Q2 2022none listed holders, n.a.25 holders, $18.1bn
Q3 20221 holders, $4.2m22 holders, $18.4bn
Q4 20221 holders, $9.9m28 holders, $18.4bn
Q1 20231 holders, $25m26 holders, $21.4bn
Q2 20231 holders, $20m27 holders, $24.7bn
Q3 20231 holders, $18m33 holders, $24.3bn
Q4 20231 holders, $23m32 holders, $28.6bn
Q1 20241 holders, $18m31 holders, $29.8bn
Q2 20241 holders, $13m29 holders, $33.4bn
Q3 20242 holders, $16m27 holders, $33.5bn
Q4 20241 holders, $6.6m26 holders, $28.5bn
Q1 20251 holders, $5.2m21 holders, $35.4bn
Q2 20251 holders, $4.6m21 holders, $32.3bn
Q3 20251 holders, $12m22 holders, $25.9bn
Q4 20251 holders, $15m26 holders, $31.8bn
Q1 20262 holders, $19m25 holders, $31.8bn
Q2 20265 holders, $191m26 holders, $34.6bn
CMPS

Compass Pathways Plc

Holders
1
Reported value
$18m
Buyers
0
Sellers
1

Breadth -1 among 93 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations
VRTX

Vertex Pharmaceuticals Inc

Holders
31
Reported value
$29.8bn
Buyers
16
Sellers
19

Breadth -3 among 93 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q1 2024

Among the 31 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only CMPS (0)

None.

Only VRTX (30)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Artisan Partners LP, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, Caxton Associates LLP, D. E. Shaw & Co., ExodusPoint Capital Management LP, Fidelity (FMR LLC), Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, Marshall Wace LLP, MFS Investment Management, Millennium Management LLC, Neuberger Berman Group LLC, PDT Partners LLC, Renaissance Technologies LLC, Schonfeld Strategic Advisors LLC, T. Rowe Price Associates Inc, Tudor Investment Corp, and 5 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →